(Reuters) – The United States Food and Drug Administration has granted emergency use authorization to Becton Dickinson and Co (BDX.N) for a COVID-19 antigen test that can be administered at the point of care and produce results in 15 minutes, the company said Monday. Becton Dickinson’s shares rose $ 5.40, …
Read More »Becton Dickinson’s rapid antigen test for FDA-approved COVID-19, stocks go up
